Ocular Therapeutix, Inc. (OCUL)

8.87 +0.46 (+5.47%) USD  |  NASDAQ  |  Feb 24, 12:49
More

Ocular Therapeutix EPS Diluted from Discontinued Operations (Quarterly)

EPS Diluted from Discontinued Operations (Quarterly) Chart

View EPS Diluted from Discontinued Operations (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Discontinued Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
Boston Scientific Corp. --
Alnylam Pharmaceuticals, Inc. --
EyePoint Plc --
Vertex Pharmaceuticals, Inc. --